Chemical Name: N-(2,6-dimethylphenyl)-4-methyl-5-oxo-3-propyl-1-(o-tolyl)imidazolidine-2-carboxamide
Smiles: CC1=C(N2C(C(NC3=C(C)C=CC=C3C)=O)N(CCC)C(C)C2=O)C=CC=C1
Inchi: InChI=1/C15H22N2O.ClH/c1-5-10-16-12(3)15(18)17(13(16)4)14-9-7-6-8-11(14)2;/h6-9,12-13H,5,10H2,1-4H3;1H
Liquid–Liquid Miscibility Gaps in Drug–Water Binary Systems: Crystal Structure and Thermodynamic Properties of Prilocaine and the Temperature–Composition Phase Diagram of the Prilocaine–Water System
Ivo B. Rietveld, Marc-Antoine Perrin, Siro Toscani, Maria Barrio, Beatrice Nicolai, Josep-Lluis Tamarit, and René Ceolin
Mol. Pharmaceutics 2013, 10, 4, 1332–1339
LC Determination of Lidocaine and Prilocaine Containing Potential Risky Impurities and Application to Pharmaceuticals
Mohammad Abdul-Azim Mohammad
Chromatographia volume 70, pages563–568(2009)
Determination of prilocaine HCL in bulk drug and pharmaceutical formulation by GC-NPD method
alptug atila, yucel kadioglu
Chemical Industry and Chemical Engineering Quarterly 19(2)
Simultaneous quantification of lidocaine and prilocaine in human plasma by LC-MS/MS and its application in a human pharmacokinetic study
Siva SankaraRao, Yadlapalli, Naresh KumarKatari, Surendra Babu, Manabolu Surya, Vijaya KumariKarra, VinuthaKommineni, Sreekantha B.Jonnalagadda
Practical Laboratory Medicine Volume 17, November 2019, e00129